Leading listed companies in IVF: Tongze Medical.
Tongze Medical Investment Company Limited (stock code: 600763SH) is a domestic main board listed company with medical investment and hospital management as its main business. With medical services as its main business direction, the company plans to enter a number of specialized medical service fields and build a modern enterprise development strategy with medical services as its pillar.
Tongze Medical, which transformed all its main businesses into medical services in 2006, is the first listed company in medical services and healthcare in the People's Republic of China. With 6,000 employees, the company has 13 dental hospitals and clinics in Hangzhou, Ningbo, Kunming, Quzhou, Beijing, Cangzhou, Huangshi, and Yiwu*** On March 18, 2020, the market value of Tongze Medical was ranked 41st in the "2020 Hurun China's 100 Strongest Healthcare Private Enterprises".
Corporate Strength
2012 In October 2012, Tongze Medical formed a strategic partnership with ACTA, the world's leading dental academy in Amsterdam, the Netherlands, to launch the global selection of academic deans and establish a core clinical education and research center.
In November 2012, we entered into a joint venture with the Bonn Clinic in Cambridge, founded by Prof. Robert Edwards, the inventor of IVF and the 2010 Nobel Laureate, to establish Bonn China, which will introduce advanced and applicable technologies and scientific management methods in the field of top international assisted reproduction IVF medical care to China. Tongze Medical plans to intervene in other medical service industries in due course to establish a large-scale medical service group; to enter the field of maternal and child healthcare, and to promote assisted reproduction programs.
The above content refers to Baidu Encyclopedia-Tongze Medical Investment Co.